585-730-8888 ddemarle@yahoo.com
  • Facebook
  • Twitter
  • Instagram
  • Facebook
  • Twitter
  • Instagram
  • Make an Appointment
  • Home
  • About Us
    • Fees
    • Available Discounts
  • Services
    • Evaluations
    • Educational Consults
    • Attending School Meetings
    • Expert Witness Services
DeMarle, Inc.
  • Ages 4 to 5
    • At Home
  • K through 12
    • Special Education Categories
    • School Districts News
    • At School
      • Assistive Technology
      • Learning and How We Learn
      • Social Skills and Bullying
      • Special Education Laws
    • At Home
  • College and Adult
    • Employment
  • Military
  • Providers
    • Professional Therapies
    • Local Resources
  • What’s New
Select Page

FDA approves first liquid, nonstimulant ADHD treatment

by Dan DeMarle | Oct 12, 2024 | ADHD, Attention Deficit Hyperactivity Disorder, Medicine, Other Health Impairment

“The U.S. Food and Drug Administration has approved Tris Pharma’s once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD). The once-a-day, extended-release, oral...

Asylum Seeker Enrollment and Immunizations from the NYSED

by Dan DeMarle | Mar 7, 2024 | Health Care, Immigration, Medicine

Newly arrived immigrant students are entitled to immediate enrollment and attendance regardless of the availability of immunization records. Per Public Health Law §2164(7)(a), schools may allow students from other states or countries to attend school for up to 30...

FDA approves generic versions of ADHD drug Vyvanse

by Dan DeMarle | Jan 15, 2024 | ADHD, Attention Deficit Hyperactivity Disorder, Medicine, Other Health Impairment

The Food and Drug Administration (FDA) approved the first generic versions of Vyvanse, a drug used to treat attention deficit/hyperactivity disorder (ADHD), a decision that comes amid a nationwide shortage of ADHD treatment drugs.  The newly approved medication...

FDA Approves Postpartum Depression Drug That Works Within Days

by Dan DeMarle | Jan 15, 2024 | Medicine, Mother's Health, Postpartum Depression

A once-daily medication taken for only 14 days was deemed safe and effective in the treatment of postpartum depression, which impacts a third of women with ADHD, according to an ADDitude survey. Postpartum Depression Drug Approved by FDA: Zuranolone Coming in Late...

Q: “What Are the Long-Term Effects of ADHD Medication on the Brain?”

by Dan DeMarle | Aug 20, 2023 | ADHD, Attention Deficit Hyperactivity Disorder, Medicine, Other Health Impairment, Uncategorized

ADHD medication use has lasting, positive effects on the brain, according to findings from brain imaging studies. Research also shows that leaving ADHD symptoms untreated carries far greater risks, including unemployment and substance abuse, than does lifelong...

Does ADHD Medication Have Long-Term Effects?

by Dan DeMarle | Aug 13, 2023 | ADHD, Attention Deficit Hyperactivity Disorder, Medicine, Other Health Impairment, Uncategorized

Yes — and findings from brain imaging studies suggest that the effects are positive. ADHD medication use has lasting, positive effects on the brain, according to findings from brain imaging studies. Research also shows that leaving ADHD symptoms untreated carries far...
« Older Entries
Next Entries »

Categories

Recent Posts

  • We need a new definition of dyslexia, research says
  • RCSD approves $1.1 billion budget
  • Trump Administration: CDC will research widely debunked link between vaccines and autism
  • The Unique Challenges Faced by Women With ADHD
  • People With Disabilities Often Feel Disrespected by Health Care Workers

Archives

Facebook Page Widget

DEMARLE INC was incorporated in 2008 and provides moderately priced, comprehensive evaluations, specific treatment services, and case management services for individuals presenting with a number of disabilities.

 

1501 East Avenue
Rochester, NY 14610

ddmarle@yahoo.com

(585) 730-8888 (office)
(585) 730-8889 (fax)

  • Make an Appointment
  • Home
  • About Us
    • Fees
    • Available Discounts
  • Services
    • Evaluations
    • Educational Consults
    • Attending School Meetings
    • Expert Witness Services
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Facebook
  • Twitter
  • Instagram
Copyright ©2020 DeMarle Inc. All Rights Reserved. Web design: philipsongroup.com